Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TCON - TRACON Pharmaceuticals announced $30M attributed to award decision expected in Q1 2023

TCON - TRACON Pharmaceuticals announced $30M attributed to award decision expected in Q1 2023

TRACON Pharmaceuticals Inc.
  • TRACON Pharmaceuticals ( NASDAQ: TCON ) announced entry into an up to $30M non-recourse financing agreement.
  • $3.5M will be funded before December 31, 2022. The additional $26.5M, or a lesser amount based on the amount awarded, will be available subject to the award exceeding a threshold and satisfaction of other conditions set forth in the agreement, with 25% of the total being available to be funded after award announcement and the remainder available over a multi-year period.

For further details see:

TRACON Pharmaceuticals announced $30M attributed to award decision expected in Q1 2023
Stock Information
Company Name: TRACON Pharmaceuticals Inc.
Stock Symbol: TCON
Market: OTC
Website: traconpharma.com
Menu
TCON TCON Quote TCON Short TCON News TCON Articles TCON Message Board
Get TCON Alerts

News, Short Squeeze, Breakout and More Instantly...